Use of a Machine Learning Model to Predict Disability Progression in Patients with Relapsing Multiple Sclerosis Treated with Ozanimod (P6-6.006)

To use a machine learning (ML) model to predict long-term clinical disability progression (CDP) in patients with relapsing multiple sclerosis (RMS) treated with ozanimod.